Document
IPR2016-01370, No. 2027-86 Exhibit - DrugsFDA Search Results for Methotrexate (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2027-86 Exhibit - DrugsFDA Search Results for Methotrexate (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2055-145 Exhibit - Stoller, Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2055-145 Exhibit - Stoller, Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2038-116 Exhibit - Goutsou, Biologics Utilization for Rheumatoid Arthritis in the United States An Observational Longitudinal Study (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2038-116 Exhibit - Goutsou, Biologics Utilization for Rheumatoid Arthritis in the United States An Observational Longitudinal Study (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2059-72 Exhibit - Antares Pharma Press Release (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2059-72 Exhibit - Antares Pharma Press Release (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2050-140 Exhibit - Smith, Systemic Therapy of Psoriasis Using Methotrexate (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2050-140 Exhibit - Smith, Systemic Therapy of Psoriasis Using Methotrexate (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2056-68 Exhibit - ASP Pricing File 2006 (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2056-68 Exhibit - ASP Pricing File 2006 (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2053-143 Exhibit - Eisenberg, Patents and Regulatory Exclusivity (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2053-143 Exhibit - Eisenberg, Patents and Regulatory Exclusivity (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2044-131 Exhibit - Menter, Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2044-131 Exhibit - Menter, Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2043-129 Exhibit - Kurd, The Prevalence of Previously Diagnosed and Undiagnosed Psoriasis in US Adults (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2043-129 Exhibit - Kurd, The Prevalence of Previously Diagnosed and Undiagnosed Psoriasis in US Adults (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2074-96 Exhibit - Highlights of Prescribing Information OXTREXUP (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2074-96 Exhibit - Highlights of Prescribing Information OXTREXUP (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2080-105 Exhibit - Methotrexate Fact Sheet (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2080-105 Exhibit - Methotrexate Fact Sheet (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2031-97 Exhibit - Parshuram, Occurrence and Impact of Unanticipated Variation in Intravenous Methotrexate Dosing (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2031-97 Exhibit - Parshuram, Occurrence and Impact of Unanticipated Variation in Intravenous Methotrexate Dosing (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2060-74 Exhibit - Supply of a Cancer Drug (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2060-74 Exhibit - Supply of a Cancer Drug (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2028-89 Exhibit - Extravasation guidelines 2007 (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2028-89 Exhibit - Extravasation guidelines 2007 (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2046-136 Exhibit - Mount, Rheumatoid Arthritis Market (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2046-136 Exhibit - Mount, Rheumatoid Arthritis Market (P.T.A.B. Jun. 9, 2017)
+ More Snippets